This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,933.30 firm fixed-price delivery order is for 4,566,659,573 units of the prescription drug Risperdal 2 mg tablets. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this specific award.
Generated 3/16/25, 12:55 AM